TrialClinical drug investigation2013

ACCORD COPD II: a randomized clinical trial to evaluate the 12-week efficacy and safety of twice-daily aclidinium bromide in chronic obstructive pulmonary disease patients.

Stephen I Rennard et al.PubMed ↗Publisher ↗

No numbers read from the abstract.